Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: New Appointments at Natera, Quanterix, Sophia Genetics, More

Natera: Monica Bertagnolli

Monica Bertagnolli has been appointed to the board of directors of Natera. She is a professor of surgery at Harvard Medical School and associate surgeon in the division of surgical oncology at Brigham and Women's Hospital and Dana-Farber Cancer Institute. In addition, she is the CEO of Alliance Foundation Trial, a nonprofit organization that conducts international cancer clinical trials, as well as VP of the Coalition of Cancer Cooperative Groups. Bertagnolli holds an undergraduate degree in engineering from Princeton University and a medical degree from the University of Utah College of Medicine.


Quanterix: William Geist

Quanterix has named William Geist as chief operating officer. Geist most recently served as vice president and general manager for two of Thermo Fisher Scientific's protein and cell analysis and qPCR business units. He also held a key leadership role in Thermo Fisher's COVID-19 task force in its biosciences division. Prior to this, Geist held numerous sales, marketing, and business development leadership roles including vice president of sales, marketing, and business development at Qiagen's Quanta BioSciences. He holds a BA in biology from Dartmouth College.


Sophia Genetics: Bram Goorden

Sophia Genetics has hired Bram Goorden as chief commercial officer and head of North American operations. Goorden, who will oversee expansion of the firm's global reach, joins Sophia from Foundation Medicine, where he was VP of international business and partnering. He previously served as general manager and head of therapeutics for Prometheus Laboratories.


Icahn School of Medicine at Mount Sinai: Alison Goate

Alison Goate has been named chair of the department of genetics and genomics sciences at the Icahn School of Medicine at Mount Sinai, effective Jan. 1, 2021.

Goate is the Willard T.C. Johnson research professor of neurogenetics and a professor of genetics and genomic science, neuroscience, and neurology. Her research focuses on genetic risk factors of neurodegenerative diseases, including Alzheimer's disease and frontotemporal dementia.

She came to Mount Sinai in 2015 as founding director of the Ronald M. Loeb Center for Alzheimer's Disease and is a member of the National Academy of Medicine and a fellow of the American Association for the Advancement of Science. Goate holds a doctorate from the University of Oxford.


For additional recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.